Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Current Leases (2023 - 2025)

Historic Current Leases for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $618000.0.

  • Zenas BioPharma's Current Leases rose 6093.75% to $618000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $618000.0, marking a year-over-year increase of 6093.75%. This contributed to the annual value of $785000.0 for FY2024, which is 4118.71% up from last year.
  • As of Q3 2025, Zenas BioPharma's Current Leases stood at $618000.0, which was up 6093.75% from $793000.0 recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Current Leases registered a high of $908000.0 during Q1 2025, and its lowest value of $384000.0 during Q3 2024.
  • Its 3-year average for Current Leases is $674000.0, with a median of $701500.0 in 2024.
  • As far as peak fluctuations go, Zenas BioPharma's Current Leases surged by 4118.71% in 2024, and later surged by 6093.75% in 2025.
  • Over the past 3 years, Zenas BioPharma's Current Leases (Quarter) stood at $556000.0 in 2023, then surged by 41.19% to $785000.0 in 2024, then fell by 21.27% to $618000.0 in 2025.
  • Its last three reported values are $618000.0 in Q3 2025, $793000.0 for Q2 2025, and $908000.0 during Q1 2025.